|Articles|January 1, 2004
- Pharmaceutical Executive-01-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 22 years ago
PE's Annual Sales and Marketing Employment Survey: The Big Squeezealmost 22 years ago
Streamlining For Success with Fred Price of BioMarinalmost 22 years ago
The Making of a New DiseaseNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
2
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
5
